First Databank
Clinical drug knowledge platform powering medication decision support in EHRs with drug interaction, dosing, and formulary data.
What it does
First Databank (FDB) is one of the leading clinical drug knowledge and medication decision support companies - providing the drug databases and clinical content that power medication management in EHRs, pharmacy systems, and clinical decision support tools across healthcare. AI capabilities include AI-enhanced drug interaction detection that identifies potentially dangerous medication combinations in patient-specific contexts, intelligent dosing guidance adjusted for patient characteristics (renal function, age, weight), automated formulary management that optimizes therapeutic substitutions, NLP drug content extraction that structures information from new pharmaceutical data sources, and real-time medication therapy management that surfaces optimization opportunities in patient medication regimens.
Strengths
- Regional hospitals and health systems use First Databank as their clinical drug knowledge backbone - AI drug interaction checking and formulary management embedded in EHR workflows supporting safe prescribing.
- Large health systems and pharmacy chains use First Databank for enterprise drug knowledge - AI medication decision support at scale supporting millions of prescriptions annually and formulary analytics optimizing medication cost and quality.
- First Databank (FDB) is one of the leading clinical drug knowledge and medication decision support companies - providing the drug databases and clinical content that power medication management in EHRs, pharmacy systems, and clinical decision support tools across healthcare.
Watch-outs
- Drug knowledge database, not standalone application: First Databank provides clinical drug data and APIs that power other applications — it is infrastructure for EHR vendors and healthcare systems, not a direct-to-clinician tool.
- Competes with Micromedex and Lexicomp: First Databank, Micromedex, and Wolters Kluwer Lexicomp are all major clinical drug knowledge providers — healthcare organizations evaluate these databases based on content depth, EHR integration, and pricing.
- Content updates require rigorous validation in regulated environments: Healthcare organizations using FDB in regulatory-sensitive contexts (pharmacy dispensing, clinical decision support) must validate content updates before deployment — update cycles add operational overhead.
Pricing
First Databank enterprise contracts based on application type, data access scope, and institutional size. Not published. Annual contracts with validation support.